These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36098476)

  • 41. Rates of Influenza and Tdap Vaccination in Teaching and Private Obstetrical Practices, and the Influence of Vaccine Hesitancy.
    Martinez CL; McLaren RA; Narayanamoorthy S; Minkoff H
    Matern Child Health J; 2023 Jul; 27(7):1272-1276. PubMed ID: 36995649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination.
    Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ
    Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
    Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
    MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination in pregnancy.
    Nassar AH; Hobeika E; Chamsy D; El-Kak F; Usta IM
    Int J Gynaecol Obstet; 2023 Jul; 162(1):18-23. PubMed ID: 37283471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surveillance Systems for Monitoring Vaccination Coverage with Vaccines Recommended for Pregnant Women, United States.
    Meghani M; Razzaghi H; Kahn KE; Hung MC; Srivastav A; Lu PJ; Ellington S; Zhou F; Weintraub E; Black CL; Singleton JA
    J Womens Health (Larchmt); 2023 Mar; 32(3):260-270. PubMed ID: 36884385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India.
    Sharma HJ; Parekh S; Pujari P; Shewale S; Desai S; Kawade A; Ravi M; Oswal J; James S; Mahantashetti N; Munshi R; Ghosh A; Rao V; Balsubramaniam S; Varughese P; Somshekhar A; Ginsburg AS; Rao H; Gautam M; Gairola S; Shaligram U
    Expert Rev Vaccines; 2023; 22(1):278-287. PubMed ID: 36883291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
    Keech C; Miller VE; Rizzardi B; Hoyle C; Pryor MJ; Ferrand J; Solovay K; Thalen M; Noviello S; Goldstein P; Gorringe A; Cavell B; He Q; Barkoff AM; Rubin K; Locht C
    Lancet; 2023 Mar; 401(10379):843-855. PubMed ID: 36906345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Waning Tdap Effectiveness in Adolescents.
    Klein NP; Bartlett J; Fireman B; Baxter R
    Pediatrics; 2016 Mar; 137(3):e20153326. PubMed ID: 26908667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
    Fortner KB; Swamy GK; Broder KR; Jimenez-Truque N; Zhu Y; Moro PL; Liang J; Walter EB; Heine RP; Moody MA; Yoder S; Edwards KM
    Vaccine; 2018 Oct; 36(42):6354-6360. PubMed ID: 30219367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.
    Jackson ML; Yu O; Nelson JC; Nordin JD; Tartof SY; Klein NP; Donahue JG; Irving SA; Glanz JM; McNeil MM; Jackson LA
    Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):921-925. PubMed ID: 29862604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal Tdap and influenza vaccination uptake 2017-2021 in the United States: Implications for maternal RSV vaccine uptake in the future.
    Law AW; Judy J; Atwell JE; Willis S; Shea KM
    Vaccine; 2023 Dec; 41(51):7632-7640. PubMed ID: 37993354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial.
    Scheifele DW; Halperin SA; Ochnio JJ; Ferguson AC; Skowronski DM
    Pediatr Infect Dis J; 2005 Dec; 24(12):1059-66. PubMed ID: 16371866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interacting, Nonspecific, Immunological Effects of Bacille Calmette-Guérin and Tetanus-diphtheria-pertussis Inactivated Polio Vaccinations: An Explorative, Randomized Trial.
    Blok BA; de Bree LCJ; Diavatopoulos DA; Langereis JD; Joosten LAB; Aaby P; van Crevel R; Benn CS; Netea MG
    Clin Infect Dis; 2020 Jan; 70(3):455-463. PubMed ID: 30919883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maternal tetanus, diphtheria, and acellular pertussis (Tdap) and influenza immunization: an overview.
    Brillo E; Tosto V; Giardina I; Buonomo E
    J Matern Fetal Neonatal Med; 2021 Oct; 34(20):3415-3444. PubMed ID: 31645152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experience and attitudes on vaccinations recommended during pregnancy: survey on an Italian sample of women and consultant gynecologists.
    Scatigna M; Appetiti A; Pasanisi M; D'Eugenio S; Fabiani L; Giuliani AR
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 33956557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccine in Adults in Japan.
    Ujiie M; Tsuzuki S; Suzuki M; Ota M; Suzuki T; Nomoto H; Yamamoto K; Saito S; Kokaze A; Kinoshita N
    Jpn J Infect Dis; 2021 Sep; 74(5):399-404. PubMed ID: 33518629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tetanus, diphtheria, and pertussis vaccine (Tdap) in pregnancy and risk of major birth defects in the offspring.
    Kerr SM; Van Bennekom CM; Mitchell AA
    Birth Defects Res; 2020 Mar; 112(5):393-403. PubMed ID: 31903700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Risk of Optic Neuritis following mRNA Coronavirus Disease 2019 Vaccination Compared to Coronavirus Disease 2019 Infection and Other Vaccinations.
    Shukla P; Sharma N; Shaia JK; Cohen DA; Singh RP; Talcott KE
    Ophthalmology; 2024 Feb; ():. PubMed ID: 38408705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine.
    Skoff TH; Deng L; Bozio CH; Hariri S
    JAMA Pediatr; 2023 Apr; 177(4):395-400. PubMed ID: 36745442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.
    Post AL; Li SH; Berry M; Itell H; Martinez DR; Xie G; Permar SR; Swamy GK; Fouda GG
    Vaccine; 2020 Jun; 38(31):4869-4876. PubMed ID: 32482459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.